Historical Stock Price
DRTX historical stock prices picture
DRTX (DRTX) has the following price history information. Looking back at DRTX historical stock prices for the last five trading days, on November 11, 2014, DRTX opened at $24.02, traded as high as $24.05 and as low as $23.97, and closed at $24.00. Trading volume was a total of 357.00K shares. On November 12, 2014, DRTX opened at $23.97, traded as high as $24.10 and as low as $23.82, and closed at $23.89. Trading volume was a total of 1.25M shares. On November 13, 2014, DRTX opened at $23.89, traded as high as $23.96 and as low as $23.75, and closed at $23.75. Trading volume was a total of 1.71M shares. On November 14, 2014, DRTX opened at $23.79, traded as high as $23.85 and as low as $23.72, and closed at $23.75. Trading volume was a total of 2.48M shares. On November 17, 2014, DRTX opened at $23.82, traded as high as $24.17 and as low as $23.80, and closed at $24.16. Trading volume was a total of 1.08M shares.

DRTX Historical Stock Prices By Date:

DRTX historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into DRTX shares, starting with a $10,000 purchase of DRTX, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/28/2014
End date: 11/17/2014
Start price/share: $13.43
End price/share: $24.16
Dividends collected/share: $0.00
Total return: 79.90%
Annualized Gain: 143.65%
Starting investment: $10,000.00
Ending investment: $17,990.00
Years: 0.56
Date Open High Low Close Volume
11/11/2014 $24.02 $24.05 $23.97 $24.00 357.00K
11/12/2014 $23.97 $24.10 $23.82 $23.89 1.25M
11/13/2014 $23.89 $23.96 $23.75 $23.75 1.71M
11/14/2014 $23.79 $23.85 $23.72 $23.75 2.48M
11/17/2014 $23.82 $24.17 $23.80 $24.16 1.08M
Durata Therapeutics is a pharmaceutical company focused on the development and commercialization of therapeutics for patients with infectious diseases and acute illnesses. Co.'s lead product candidate is dalbavancin, for the treatment of patients with acute bacterial skin and skin structure infections caused by Gram-positive bacteria, such as S. aureus, including Methicillin-Resistant and multi-drug resistant strains, and certain Streptococcal species. Dalbavancin is a second generation, semi-synthetic lipoglycopeptide designed for once-weekly intravenous dosing. Dalbavancin can be delivered through any intravenous catheter, which can be removed after dosing is complete.
Date Close
11/11/2014$24.00
11/12/2014$23.89
11/13/2014$23.75
11/14/2014$23.75
11/17/2014$24.16
DRTX is categorized under the Healthcare sector; below are some other companies in the same sector:

DSCI Historical Stock Prices
DSCO Historical Stock Prices
DVA Historical Stock Prices
DVAX Historical Stock Prices
DVCR Historical Stock Prices
DXCM Historical Stock Prices
DXTR Historical Stock Prices
DYAX Historical Stock Prices
DYNT Historical Stock Prices
EBIO Historical Stock Prices

Email EnvelopeFree DRTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


DRTX Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.